MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-MH-19-0156395
Clemetiz Pharmaceuticals Private Limited
Clemetiz Pharmaceuticals Private Limited - food and beverages in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.76 Cr
▼ 45% YoY
Net profit · FY 2025
₹4.16 Lakh
Net margin 2.4%
EBITDA · FY 2025
₹6.78 Lakh
EBITDA margin 3.8%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹25 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Clemetiz Pharmaceuticals Private Limited
Data last updated:
Clemetiz Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 01 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2019PTC318931. Its GSTIN is 27AAHCC9362M1Z1 (Maharashtra).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors Asifbeg Karimbeg Mirza and Sadaf Bano Mohd Akram Shaikh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Vishwanath Tawade B. No 11 R.No 101 1 Floor Ahamadabad Rd Sankraman Shibir, Mumbai, Maharashtra, India – 400065.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.76 Cr, a decline of 45% compared to the previous year. For the same year it recorded a net profit of ₹4.16 Lakh (net margin 2.4%) and EBITDA of ₹6.78 Lakh (EBITDA margin 3.8%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 189% over five years.
Clemetiz Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0156395).
Company details
CIN U24304MH2019PTC318931
Registration Number 318931
Incorporation Date 01 January 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0156395
Recognitions & Rankings of Clemetiz Pharmaceuticals
Contact details
Clemetiz Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Vishwanath Tawade B. No 11 R.No 101 1 Floor Ahamadabad Rd Sankraman Shibir, Mumbai, Maharashtra, India – 400065
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
To see the full contact details of Clemetiz Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Clemetiz Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Clemetiz Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Clemetiz Pharmaceuticals Private Limited, buy the company report.
Financials of Clemetiz Pharmaceuticals Private Limited
FY 2025 filings availableClemetiz Pharmaceuticals Private Limited reported revenue of ₹1.76 Cr (down 45% YoY) for FY 2025.
Revenue · FY 2025
₹1.76 Cr ▼ 45%
Net profit · FY 2025
₹4.16 Lakh margin 2.4%
EBITDA · FY 2025
₹6.78 Lakh margin 3.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 45%
3 years · compounded
▲ 9%
5 years · compounded
▲ 189%
EBITDA CAGR growth
1 year
▼ 27%
3 years · compounded
▲ 33%
5 years · compounded
▲ 25%
Revenue fell 45% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 189%. EBITDA fell 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.78 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.16 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.8% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Clemetiz Pharmaceuticals Private Limited, buy the company report.
Board of directors of Clemetiz Pharmaceuticals Private Limited
Clemetiz Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Asifbeg Karimbeg Mirza | Director | 15 Apr 2019 | 7 Years 6 Months | Current |
| Sadaf Bano Mohd Akram Shaikh | Director | 30 Dec 2023 | 2 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Clemetiz Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Clemetiz Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Clemetiz Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCC9362M1Z1 | Maharashtra | Active | 01 Jan 2019 |
To see the full GST registrations and return filing status of Clemetiz Pharmaceuticals Private Limited, buy the company report.
Recent activity
Clemetiz Pharmaceuticals Private Limited has 6 board changes on record since 2019: 4 appointments and 2 cessations. The latest: Aneesbeg Aasifbeg Mirza ceased to be Director on 02 Jan 2024.
AGM
Clemetiz Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Clemetiz Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Aneesbeg Aasifbeg Mirza ceased to be Director.
Appointed
Sadaf Bano Mohd Akram Shaikh was appointed as Director.
Ceased
Mahesh Naval Patil ceased to be Director.
Appointed
Asifbeg Karimbeg Mirza was appointed as Director.
Appointed
Aneesbeg Aasifbeg Mirza was appointed as Director.
Appointed
Mahesh Naval Patil was appointed as Director.
Incorporation
01 Jan 2019
Clemetiz Pharmaceuticals Private Limited was registered on 01 Jan 2019 with Roc Mumbai I & aged 7 years 10 months as per MCA records.
Frequently asked questions
Clemetiz Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 01 January 2019 (7+ years old) and is registered under CIN U24304MH2019PTC318931.
Clemetiz Pharmaceuticals has 2 current directors:
- Asifbeg Karimbeg Mirza - Director
- Sadaf Bano Mohd Akram Shaikh - Director
The latest financial statements of Clemetiz Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Clemetiz Pharmaceuticals is 27AAHCC9362M1Z1, registered in Maharashtra.
The CIN (Corporate Identification Number) of Clemetiz Pharmaceuticals is U24304MH2019PTC318931. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Clemetiz Pharmaceuticals was incorporated on 01 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
Aneesbeg Aasifbeg Mirza ceased to be Director on 02 Jan 2024. Sadaf Bano Mohd Akram Shaikh was appointed as Director on 30 Dec 2023. Mahesh Naval Patil ceased to be Director on 23 Apr 2019. Clemetiz Pharmaceuticals has 6 board changes on record in total.
Yes, Clemetiz Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0156395).
The registered office of Clemetiz Pharmaceuticals is at CO Vishwanath Tawade B. No 11 R.No 101 1 Floor Ahamadabad Rd Sankraman Shibir, Mumbai, Maharashtra, India – 400065.
Clemetiz Pharmaceuticals operates in the food and beverages industry, in the manufacturing segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages